IMU is starting to get some press in the US with NASDAQ associate RenovoRx (RNXT)
Renovo announced a strategic research collaboration to optimize the delivery of IMU’s oncolytic virus therapy with RenovoRx’s TAMP (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of difficult-to-access tumors.
Also, with a director of NASDAQ Kineta (KA) on our board, we can't help but being noticed in the US space.
RNXT (white plot) / IMU (green) pair comparison.
IMO DYOR
IMUGENE CHART. TA only, page-24544
-
- There are more pages in this discussion • 8,613 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.003(5.26%) |
Mkt cap ! $395.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.7¢ | 5.4¢ | $1.444M | 26.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 3824179 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 172983 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |